Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

CENP-I Activators

CENP-I (Centromere Protein I) is a crucial component of the centromere, a specialized region on chromosomes essential for proper chromosome segregation during cell division. The activation or modulation of CENP-I is of interest in cell biology research to understand its role in maintaining genome stability and faithful chromosome segregation. Various chemicals and biological processes can indirectly influence CENP-I function by affecting centromere dynamics and integrity.

One group of compounds that can indirectly activate or modulate CENP-I are those involved in cell cycle regulation. For instance, CDK (Cyclin-Dependent Kinase) inhibitors like Roscovitine can impact CENP-I by altering the progression of the cell cycle. By inhibiting CDKs, Roscovitine can influence the timing of centromere events, ensuring proper chromosome alignment and segregation. Similarly, Aurora kinase inhibitors such as VX-680 can indirectly activate CENP-I by promoting centromere stability during cell division. These compounds interfere with key regulators of the cell cycle and centromere function, affecting CENP-I as part of this intricate process. Additionally, epigenetic modifiers like SAHA (Suberanilohydroxamic Acid, also known as Vorinostat) can indirectly influence CENP-I. SAHA is an HDAC (Histone Deacetylase) inhibitor that affects chromatin structure and gene expression. Given that centromere function is intricately linked to chromatin dynamics, SAHA can modulate the transcription of genes related to centromere stability and indirectly impact CENP-I function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$61.00
$85.00
4
(1)

Tozasertib (VX-680) inhibits Aurora kinases, indirectly activating CENP-I by promoting centromere stability during cell division.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Roscovitine inhibits CDKs, indirectly influencing CENP-I by modulating cell cycle progression and centromere dynamics.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

SAHA is an HDAC inhibitor that indirectly affects CENP-I by altering chromatin structure and gene expression related to centromere stability.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 inhibits the proteasome, indirectly influencing CENP-I by maintaining its protein levels and stability.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Taxol disrupts microtubules, indirectly affecting CENP-I by influencing centromere-microtubule interactions during mitosis.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide inhibits topoisomerases, indirectly impacting CENP-I through DNA structure-related processes affecting centromere stability.

GSK 923295

1088965-37-0sc-490136
5 mg
$290.00
(0)

GSK-923295 indirectly influences CENP-I by affecting processes related to mitotic progression and centromere function.

BI 2536

755038-02-9sc-364431
sc-364431A
5 mg
50 mg
$148.00
$515.00
8
(1)

BI 2536 inhibits Plk1, indirectly impacting CENP-I function related to centromere stability during cell division.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine (Decitabine) indirectly influences CENP-I through epigenetic modifications affecting centromere structure and stability.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin induces DNA damage responses, indirectly influencing CENP-I-related centromere stability through cellular stress responses.